HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > PennyStockPickAlert.com

Print e mail rss del Y! myWeb Tweet
 

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Is the Top Active Stock on NASDAQ

ARIAD Pharmaceuticals, Inc. Announces Result Of First Interim Analysis Of Phase 3 Succeed Trial Of Oral Ridaforolimus

(EMAILWIRE.COM, September 14, 2009 ) New York, NY - PennyStockPickAlert is pleased to alert investors of stocks on the move.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is amongst the top traded stock in few minutes. The stock is being traded at $2.78 and surged by 6.07% with a huge volume of 4.07 million shares. Today September 14, 2009 ARIAD Pharmaceuticals, Inc. announced that the independent Data Monitoring Committee (DMC) of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis as specified by the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to full patient enrollment and completion. The DMC made this recommendation after reviewing the pre-specified statistical analyses and available data on the safety and efficacy of oral ridaforolimus. However the yield till date of the stock in this calendar year is 234.13%. ARIAD Pharmaceuticals, Inc. (ARIAD) is a biopharmaceutical company engaged in the discovery and development of medicines to treat cancers by regulating cell signaling with small molecules. The Company’s lead cancer product candidate, deforolimus, is an internally discovered, potent inhibitor of the protein mTOR, a master switch in cancer cells. Blocking mTOR creates a starvation-like effect in cancer cells by interfering with cell growth, division, metabolism and angiogenesis. Its second product candidate, AP24534, is a multi-targeted kinase inhibitor that has potential applications in cancer and is wholly owned by the Company.

Penny Stock Pick Alert alerts its members on stocks that could generate higher than average returns. These include stocks with huge volume, penny stocks that are moving to the upside quickly, hot penny stocks with buy signals and companies with news. Our penny stock newsletter is well known for producing incredible results in a short amount of time and our members have made outstanding profits of over 100%. We encourage investors to join our FREE e-mail alerts by visiting Penny Stock Pick Alert

ABOUT Penny Stock Pick Alert

Investors who are interested in hot stocks on the move and making money in the stock market can receive FREE Alerts by visiting Penny Stock Pick Alert PennyStockPickAlert.com is a leading stock web site that provides free stock alerts on stocks that are poised to make big gains. PennyStockPickAlert.com also tracks small cap penny stocks that could be on the brink of a massive breakout. To feature a company on our web site please contact us at info@PennyStockPickAlert.com

Contact Information:
PennyStockPickAlert.com
Editorial Staff
Tel: 214-556-6798
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012